About: Can serum 17-hydroxyprogesterone and insulin-like factor 3 be used as a marker for evaluation of intratesticular testosterone?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Can serum 17-hydroxyprogesterone and insulin-like factor 3 be used as a marker for evaluation of intratesticular testosterone? Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 March 2019

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в березні 2019 (uk) im März 2019 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en marzu de 2019 (ast) scientific article published on 01 March 2019 (en)
publication date	wds:Q64246674-B4EEEDA0-5252-41B7-A186-C16E40CBDF17
publication date	2019-03-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q64246674-2A4CCB09-CEE6-4FE7-9D0C-06C71F38E55D
language of work or name	English
cites work	wds:Q64246674-066E0753-D164-40E9-80C5-0E2349C8C7C7 wds:Q64246674-29771BB9-5F04-4C45-ABDB-C2730E0818D4 wds:Q64246674-2B4D9010-2704-40ED-96B4-3BF03F1277E6 wds:Q64246674-31480562-2A58-4816-910B-590C2D517F92 wds:Q64246674-357CB545-E056-4FF0-AFD0-8027C1364EC3 wds:Q64246674-3C46F5A7-7130-40CC-9DDA-33BBDA1AEDD6 wds:Q64246674-3D436649-8A8E-4386-9FB7-93DD0926DA4A wds:Q64246674-3D66E3A5-CF3C-4358-8401-A977845DD1F6 wds:Q64246674-429613D0-8FB1-4B72-B758-909E9F8A1D47 wds:Q64246674-5B920D1B-98AB-4212-B475-4614C9BE56BB wds:Q64246674-5C24C437-AA75-499E-B408-4D4F31B785F0 wds:Q64246674-6453E304-8163-4174-B771-E59104B8F10E wds:Q64246674-69768364-52D3-4CF0-8B3E-8F7C41F833BC wds:Q64246674-729602C3-01D3-4EC6-970C-F1D59E091E7D wds:Q64246674-755D41EA-EDDE-4684-902C-452FC54A5493 wds:Q64246674-7D5E10DC-FA27-4203-936F-6B4B98876E29 wds:Q64246674-99FAD0FD-E4E1-446B-B734-20CEE06BE033 wds:Q64246674-B836B25E-A81D-486E-8E16-41DF95BC03BA wds:Q64246674-C3DF4A0D-CED0-4939-A99D-5EEF51B5318A wds:Q64246674-CCD31116-20ED-402D-A183-3AB449A8478B wds:Q64246674-D22E7608-2E82-468E-B300-9A7411ACCDF9 wds:Q64246674-F463BFFA-B4FA-4832-807A-3AC71940CE6D
cites work	Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production INSL3 as a biomarker of Leydig cell functionality Insulin-like factor 3 serum levels in 135 normal men and 85 men with testicular disorders: relationship to the luteinizing hormone-testosterone axis Regulation of testicular function in men: implications for male hormonal contraceptive development Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. The effects of gonadotropin suppression and selective replacement on insulin-like factor 3 secretion in normal adult men. Hormonal regulation of spermatogenesis in primates and man: insights for development of the male hormonal contraceptive. Contraceptive efficacy of testosterone-induced azoospermia in normal men. World Health Organization Task Force on methods for the regulation of male fertility Daily testosterone and gonadotropin levels are similar in azoospermic and nonazoospermic normal men administered weekly testosterone: implications for male contraceptive development Relationship between serum gonadotropins and spermatogenic suppression in men undergoing steroidal contraceptive treatment Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone Dose-dependent increase in intratesticular testosterone by very low-dose human chorionic gonadotropin in normal men with experimental gonadotropin deficiency Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression Follicle-stimulating hormone and human spermatogenesis Maintenance of spermatogenesis in hypogonadotropic hypogonadal men with human chorionic gonadotropin alone. Serum insulin-like factor 3 is highly correlated with intratesticular testosterone in normal men with acute, experimental gonadotropin deficiency stimulated with low-dose human chorionic gonadotropin: a randomized, controlled trial Serum 17-hydroxyprogesterone strongly correlates with intratesticular testosterone in gonadotropin-suppressed normal men receiving various dosages of human chorionic gonadotropin Orchidectomy or oestrogen treatment in prostatic cancer: effects on serum levels of adrenal androgens and related steroids Adrenocortical function in prostatic cancer patients: effects of orchidectomy or different modes of estrogen treatment on basal steroid levels and on the response to exogenous adrenocorticotropic hormone Intratesticular testosterone concentrations comparable with serum levels are not sufficient to maintain normal sperm production in men receiving a hormonal contraceptive regimen. Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy Congenital adrenal hyperplasia: not really a zebra.
author name string	wds:Q64246674-5C52F836-7A89-4DDD-A233-75D805A91270 wds:Q64246674-81AFE805-17FB-452A-AFD6-A5319F608CE5 wds:Q64246674-D02933AB-4264-494C-9880-6D7A90F70958
author name string	Premal Patel Joshua Bitran Ashaka Patel
rdfs:label	Can serum 17-hydroxyprogesterone and insulin-like factor 3 be used as a marker for evaluation of intratesticular testosterone? (en) Can serum 17-hydroxyprogesterone and insulin-like factor 3 be used as a marker for evaluation of intratesticular testosterone? (nl)
skos:prefLabel	Can serum 17-hydroxyprogesterone and insulin-like factor 3 be used as a marker for evaluation of intratesticular testosterone? (en) Can serum 17-hydroxyprogesterone and insulin-like factor 3 be used as a marker for evaluation of intratesticular testosterone? (nl)
name	Can serum 17-hydroxyprogesterone and insulin-like factor 3 be used as a marker for evaluation of intratesticular testosterone? (en) Can serum 17-hydroxyprogesterone and insulin-like factor 3 be used as a marker for evaluation of intratesticular testosterone? (nl)
author	wds:Q64246674-23DCAAC2-A6B9-4263-BF05-48BF9B80FEAD
author	Ranjith Ramasamy
title	wds:Q64246674-CE488C53-FB1A-4E55-870E-AA93E1D5CA13
title	Can serum 17-hydroxyprogesterone and insulin-like factor 3 be used as a marker for evaluation of intratesticular testosterone? (en)
page(s)	wds:Q64246674-127A1FE0-E330-45FF-877A-CB0D44F9BA92
page(s)	S58-S63
instance of	wds:Q64246674-7747EEB2-5DF6-4704-AC89-DD51DE2CE109 wds:Q64246674-7cf2dd23-0026-4c27-ab1f-c921e060c8fc
instance of	review article scholarly article
main subject	wds:Q64246674-C27CC14B-18F4-440F-9687-542C467AD655 wds:Q64246674-F61A549D-0281-4A08-A375-001331A80D46
main subject	reproductive medicine urology
PubMed ID	wds:Q64246674-8BEE770C-5026-4584-8E82-C46B4476865E
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31143672
PubMed ID	31143672
published in	wds:Q64246674-2508867E-A4CB-47EF-BFBC-58A0001F53B5
published in	Translational andrology and urology
issue	wds:Q64246674-255C2BE9-F75E-4DC4-AB9F-371580C4DDFB
volume	wds:Q64246674-4FAA755F-7406-4EA8-8A45-C645C4CFE3A6
issue	Suppl 1
volume	8
DOI	wds:Q64246674-158B9591-F09C-4BFF-B9CB-AEF72415B9B4
DOI	http://dx.doi.org/10.21037/TAU.2019.01.16
DOI	10.21037/TAU.2019.01.16
PMCID	wds:Q64246674-F71A94D3-F806-42C5-A8F5-D3EC6B4B5F33
PMCID	6511701
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q64246674
is cites work of	Association of aging and obesity with decreased 17-hydroxyprogesterone, a serum biomarker of intratesticular testosterone Using 17-OHP as Serum Biomarker to Monitor Therapy in Patients With Hypogonadotropic Hypogonadism Effect of microsurgical varicocelectomy on semen parameters, serum, and intratesticular testosterone levels
is cites work of	wds:Q100428126-D7A26054-6A9B-4FB2-A640-DE489B740E73 wds:Q89768177-C31AED3A-6574-4B68-93CC-2846F966A113

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software